Anthropic Enters Drug Discovery Market with $400M Biotech Acquisition

Anthropic's $400 million acquisition of Coefficient Bio marks a significant expansion into healthcare and life sciences applications. The deal brings together Anthropic's Claude AI capabilities with experienced biotech researchers from Genentech's Prescient Design team, positioning the company to lead in AI-driven drug discovery. This strategic move complements Anthropic's October launch of Claude for Life Sciences and reflects growing demand for AI tools in pharmaceutical development.